238:/scientists-rankings/medicine/at). In total, his work has been cited more than 35,000 times by March 2019 and his h-index is 103 (as of April 2022). Peter Valent is currently ranked #777 among the world's top scientists in Biology and Biochemistry as of April 2022, and #913 among the world's top scientists in Medicine as of June 2022 -
663:
Valent, Peter; Arock, Michel; Bonadonna, Patrizia; Brockow, Knut; Broesby-Olsen, Sigurd; Escribano, Luis; Gleixner, Karoline V.; Grattan, Clive; Hadzijusufovic, Emir; Hägglund, Hans; Hermine, Olivier (1 December 2012). "European
Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and
233:
Valent is a member of numerous scientific organizations and has published over 850 publications since 1988, including more than 500 original papers, over 200 review articles and numerous book contributions. He also published numerous textbook chapters. In 2001, 2008 and 2016 he drew book chapters on
209:
One additional focus in Valent´s research is the neoplastic stem cell, also termed cancer stem cell in the context of cancer and leukemic stem cell in leukemia contexts. Valent investigates the phenotype of these cells in various hematologic neoplasms and develops concepts predicting the step-wise
192:
that expanded rapidly and provides a useful basis for the development and conduct of studies and activities in the field of mastocytosis. In the forthcoming years, the diagnostic WHO criteria of mastocytosis were validated, adjusted and extended. To discuss these developments, Valent and his team
179:
Between 1989 and 1999 Valent examined the phenotype and growth characteristics of human mast cells. He found that mast cells form a unique lineage in the hematopoietic cell system. In subsequent studies, neoplastic mast cells were characterized. The resulting data contributed essentially to the
234:
mastocytosis as the author of the WHO. Peter Valent is one of the most frequently cited scientists from German-speaking countries in the field of immunology from 2011 to 2015. In
Austria he is one of the top 5 scientists in the field of medicine (as of June 2022 -
210:
development of these cells from normal stem cells. The major aim in his research is to identify molecular targets in these cells and to develop more effective (curative) therapies by eliminating these cells in various blood cell disorders, including
572:
Valent, Peter; Horny, HP; Escribano, L; Longley, BJ; Li, CY; Schwartz, LB; Marone, G; Nuñez, R; Akin, C; Sotlar, K; Sperr, WR; Wolff, K; Parwaresch, RM; Brunning, RD; Austen, KF; Lennert, K; Metcalfe, DD; Vardiman, JW; Bennett, JM (2001).
954:
Valent, Peter; Orazi, Attilio; Steensma, David P.; Ebert, Benjamin L.; Haase, Detlef; Malcovati, Luca; van de
Loosdrecht, Arjan A.; Haferlach, Torsten; Westers, Theresia M.; Wells, Denise A.; Giagounidis, Aristoteles (26 September 2017).
789:
Valent, Peter; Akin, Cem; Arock, Michel; Brockow, Knut; Butterfield, Joseph H.; Carter, Melody C.; Castells, Mariana; Escribano, Luis; Hartmann, Karin; Lieberman, Philip; Nedoszytko, Boguslaw (2012).
846:
Valent, Peter; Sadovnik, Irina; Eisenwort, Gregor; Bauer, Karin; Herrmann, Harald; Gleixner, Karoline V.; Schulenburg, Axel; Rabitsch, Werner; Sperr, Wolfgang R.; Wolf, Dominik (29 August 2019).
188:. In 2000, Valent organized a Working Conference on Mastocytosis to implement this classification together with an international consensus group. Since 2002 Valent coordinates the
740:
Valent, P.; Akin, C.; Escribano, L.; Födinger, M.; Hartmann, K.; Brockow, K.; Castells, M.; Sperr, W. R.; Kluin-Nelemans, H. C.; Hamdy, N. A. T.; Lortholary, O. (1 June 2007).
158:
in 1992 and
Associate Professor for Internal Medicine in 1995. Valent visited several universities in Germany as Guest Scientist, including the Institute of Pathology of the
290:
791:"Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal"
1101:
1096:
406:
Valent, Peter; Bettelheim, P. (1992). "Cell
Surface Structures on Human Basophils and Mast Cells: Biochemical and Functional Characterization".
365:
Valent, Peter; Bettelheim, P. (1992). "Cell
Surface Structures on Human Basophils and Mast Cells: Biochemical and Functional Characterization".
1038:
163:
1106:
340:
742:"Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response Criteria"
1121:
423:
382:
282:
1091:
1111:
535:
Phenotypic heterogeneity, novel diagnostic markers, and target expression profiles in normal and neoplastic human mast cells
486:
Valent, Peter; Schernthaner, GH; Sperr, WR; Fritsch, G; Agis, H; Willheim, M; BĂĽhring, HJ; Orfao, A; Escribano, L (2001). "
131:
1013:
143:
119:
70:
612:
Valent, Peter (1 June 2010). "Classification and response criteria in mastocytosis: is there a need to revise?".
181:
159:
533:
Valent, Peter; Cerny-Reiterer, S; Herrmann, H; Mirkina, I; George, TI; Sotlar, K; Sperr, WR; Horny, HP (2010). "
223:
215:
278:
155:
957:"Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions"
1116:
1081:
211:
195:
Working
Conference on Standards and Standardization of Diagnostic Criteria and Therapies in Mastocytosis
1086:
488:
Variable expression of activation-linked surface antigens on human mast cells in health and disease.
715:
697:
645:
515:
994:
976:
936:
928:
887:
869:
828:
810:
771:
763:
689:
681:
637:
629:
594:
554:
507:
468:
429:
419:
388:
378:
147:
984:
968:
918:
877:
859:
818:
802:
753:
673:
621:
586:
546:
499:
460:
411:
370:
252:
989:
956:
882:
847:
823:
790:
590:
503:
415:
374:
1075:
848:"Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CML"
758:
741:
464:
649:
519:
219:
185:
111:
701:
449:
The riddle of the mast cell: kit(CD117)-ligand as the missing link? Immunol Today.
923:
906:
550:
199:
Global
Classification of Mast Cell Disorders and Mast Cell Activation Syndromes
972:
677:
151:
87:
980:
932:
873:
814:
767:
685:
633:
575:
Diagnostic criteria and classification of mastocytosis: a consensus proposal
115:
998:
940:
891:
832:
775:
693:
641:
598:
558:
511:
1066:
472:
433:
392:
314:
864:
250:
Valent received several national and international awards, including the
107:
51:
806:
625:
103:
47:
239:
905:
Valent, Peter; Sperr, Wolfgang R.; Akin, Cem (23 December 2010).
162:, the University of Schleswig-Holstein (Campus LĂĽbeck) and the
295:
Middle
European Award for Interdisciplinary Cancer Research
907:"How I treat patients with advanced systemic mastocytosis"
175:
Mast cell research and the classification of mastocytosis
193:
organized additional conferences in Vienna, including a
118:
researcher. Since 1990 he leads a research group at the
235:
1067:
Ludwig
Boltzmann Institute for Hematology and Oncology
228:
Ludwig Boltzmann Institute for Hematology and Oncology
128:
Ludwig Boltzmann Institute for Hematology and Oncology
83:
66:
58:
30:
23:
795:International Archives of Allergy and Immunology
126:and since 2008 he is Scientific Director of the
226:. These studies are primarily conducted in the
16:Austrian hematologist and stem cell researcher
146:and graduated in 1987. He is a specialist in
8:
275:Austrian Society for Hematology and Oncology
154:and was promoted to Assistant Professor for
852:International Journal of Molecular Sciences
291:European Society for Clinical Investigation
259:Austrian Society for Allergy and Immunology
190:European Competence Network on Mastocytosis
180:development of diagnostic criteria and the
124:European Competence Network on Mastocytosis
746:European Journal of Clinical Investigation
20:
988:
922:
881:
863:
822:
757:
306:
267:Austrian Society for Internal Medicine
230:at the Medical University of Vienna.
7:
205:Additional scientific contributions
410:. Vol. 52. pp. 333–423.
369:. Vol. 52. pp. 333–423.
14:
504:10.1034/j.1600-065x.2001.790108.x
1102:20th-century Austrian physicians
1097:21st-century Austrian physicians
759:10.1111/j.1365-2362.2007.01807.x
408:Advances in Immunology Volume 52
367:Advances in Immunology Volume 52
240:https://research.com/scientists-
142:Valent studied medicine at the
122:. From 2002 he coordinates the
1039:"Univ.-Prof. Dr. Peter Valent"
666:Wiener klinische Wochenschrift
341:"Peter Valent - Scientific CV"
1:
1043:Medizinische Universität Wien
591:10.1016/s0145-2126(01)00038-8
416:10.1016/s0065-2776(08)60879-2
375:10.1016/s0065-2776(08)60879-2
345:Medizinische Universität Wien
1107:Austrian medical researchers
1018:International CML Foundation
1014:"Professor Peter Valent, MD"
924:10.1182/blood-2010-08-292144
539:Best Pract Res Clin Haematol
465:10.1016/0167-5699(94)90153-8
283:Austrian Medical Association
144:Medical University of Vienna
120:Medical University of Vienna
71:Medical University of Vienna
614:Expert Review of Hematology
1138:
551:10.1016/j.beha.2010.07.003
319:Ludwig Boltzmann Institute
973:10.18632/oncotarget.19008
678:10.1007/s00508-012-0293-z
224:Myelodysplastic Syndromes
93:
76:
1122:Medical textbook writers
216:Chronic Myeloid Leukemia
170:Scientific contributions
132:Ludwig Boltzmann Society
102:(born 9 October 1962 in
447:Valent, Peter (1994). "
156:Experimental Hematology
1092:Scientists from Vienna
1012:Bockwinkel, Stefanie.
664:future perspectives".
279:Theodor-Billroth Medal
212:Acute Myeloid Leukemia
160:University of TĂĽbingen
1112:Stem cell researchers
220:Systemic Mastocytosis
865:10.3390/ijms20174233
242:rankings/medicine).
236:https://research.com
967:(43): 73483–73500.
716:"Peter VALENT, MD"
672:(23–24): 807–814.
321:. 10 December 2008
271:Wilhelm TĂĽrk Award
184:classification of
138:Life and education
917:(26): 5812–5817.
807:10.1159/000328760
626:10.1586/ehm.10.20
287:Mac Forster Award
148:internal medicine
110:) is an Austrian
97:
96:
78:Scientific career
1129:
1054:
1053:
1051:
1049:
1035:
1029:
1028:
1026:
1024:
1009:
1003:
1002:
992:
951:
945:
944:
926:
902:
896:
895:
885:
867:
843:
837:
836:
826:
786:
780:
779:
761:
737:
731:
730:
728:
726:
712:
706:
705:
660:
654:
653:
609:
603:
602:
569:
563:
562:
530:
524:
523:
483:
477:
476:
453:Immunology Today
444:
438:
437:
403:
397:
396:
362:
356:
355:
353:
351:
337:
331:
330:
328:
326:
311:
263:Paracelsus Award
253:Karl Landsteiner
44:
40:
38:
21:
1137:
1136:
1132:
1131:
1130:
1128:
1127:
1126:
1072:
1071:
1063:
1058:
1057:
1047:
1045:
1037:
1036:
1032:
1022:
1020:
1011:
1010:
1006:
953:
952:
948:
904:
903:
899:
845:
844:
840:
788:
787:
783:
739:
738:
734:
724:
722:
714:
713:
709:
662:
661:
657:
611:
610:
606:
571:
570:
566:
532:
531:
527:
485:
484:
480:
446:
445:
441:
426:
405:
404:
400:
385:
364:
363:
359:
349:
347:
339:
338:
334:
324:
322:
313:
312:
308:
303:
248:
207:
197:and one on the
177:
172:
140:
67:Alma mater
54:
45:
42:
36:
34:
26:
17:
12:
11:
5:
1135:
1133:
1125:
1124:
1119:
1114:
1109:
1104:
1099:
1094:
1089:
1084:
1074:
1073:
1070:
1069:
1062:
1061:External links
1059:
1056:
1055:
1030:
1004:
946:
897:
838:
801:(3): 215–225.
781:
752:(6): 435–453.
732:
707:
655:
620:(3): 247–249.
604:
585:(7): 603–625.
564:
545:(3): 369–378.
525:
498:(179): 74–81.
478:
459:(3): 111–114.
439:
424:
398:
383:
357:
332:
315:"Peter Valent"
305:
304:
302:
299:
247:
244:
206:
203:
176:
173:
171:
168:
139:
136:
95:
94:
91:
90:
85:
81:
80:
74:
73:
68:
64:
63:
60:
56:
55:
46:
41:9 October 1962
32:
28:
27:
24:
15:
13:
10:
9:
6:
4:
3:
2:
1134:
1123:
1120:
1118:
1117:Hematologists
1115:
1113:
1110:
1108:
1105:
1103:
1100:
1098:
1095:
1093:
1090:
1088:
1085:
1083:
1082:Living people
1080:
1079:
1077:
1068:
1065:
1064:
1060:
1044:
1040:
1034:
1031:
1019:
1015:
1008:
1005:
1000:
996:
991:
986:
982:
978:
974:
970:
966:
962:
958:
950:
947:
942:
938:
934:
930:
925:
920:
916:
912:
908:
901:
898:
893:
889:
884:
879:
875:
871:
866:
861:
857:
853:
849:
842:
839:
834:
830:
825:
820:
816:
812:
808:
804:
800:
796:
792:
785:
782:
777:
773:
769:
765:
760:
755:
751:
747:
743:
736:
733:
721:
717:
711:
708:
703:
699:
695:
691:
687:
683:
679:
675:
671:
667:
659:
656:
651:
647:
643:
639:
635:
631:
627:
623:
619:
615:
608:
605:
600:
596:
592:
588:
584:
580:
576:
568:
565:
560:
556:
552:
548:
544:
540:
536:
529:
526:
521:
517:
513:
509:
505:
501:
497:
493:
489:
482:
479:
474:
470:
466:
462:
458:
454:
450:
443:
440:
435:
431:
427:
425:9780120224524
421:
417:
413:
409:
402:
399:
394:
390:
386:
384:9780120224524
380:
376:
372:
368:
361:
358:
346:
342:
336:
333:
320:
316:
310:
307:
300:
298:
296:
292:
288:
284:
280:
276:
272:
268:
264:
260:
256:
254:
245:
243:
241:
237:
231:
229:
225:
221:
217:
213:
204:
202:
200:
196:
191:
187:
183:
174:
169:
167:
165:
161:
157:
153:
149:
145:
137:
135:
133:
129:
125:
121:
117:
113:
109:
105:
101:
92:
89:
86:
82:
79:
75:
72:
69:
65:
61:
57:
53:
49:
43:(age 61)
33:
29:
22:
19:
1046:. Retrieved
1042:
1033:
1021:. Retrieved
1017:
1007:
964:
960:
949:
914:
910:
900:
858:(17): 4233.
855:
851:
841:
798:
794:
784:
749:
745:
735:
723:. Retrieved
719:
710:
669:
665:
658:
617:
613:
607:
582:
578:
574:
567:
542:
538:
534:
528:
495:
491:
487:
481:
456:
452:
448:
442:
407:
401:
366:
360:
348:. Retrieved
344:
335:
323:. Retrieved
318:
309:
294:
286:
274:
270:
266:
262:
258:
251:
249:
232:
227:
208:
198:
194:
189:
186:mastocytosis
178:
141:
134:in Austria.
127:
123:
112:hematologist
100:Peter Valent
99:
98:
77:
25:Peter Valent
18:
1087:1962 births
492:Immunol Rev
59:Nationality
1076:Categories
961:Oncotarget
301:References
164:LMU Munich
152:hematology
88:Hematology
37:1962-10-09
981:1949-2553
933:0006-4971
874:1422-0067
815:1423-0097
768:0014-2972
686:0043-5325
634:1747-4086
116:stem cell
999:29088721
941:20855864
892:31470642
833:22041891
776:17537151
720:PhD MCCA
694:23179435
650:36767409
642:21082975
599:11377686
579:Leuk Res
559:21112036
520:45298998
512:11292030
350:13 March
325:13 March
293:and the
201:(2010).
62:Austrian
1048:8 April
1023:8 April
990:5650276
883:6747233
824:3224511
725:8 April
473:7513517
434:1332448
393:1332448
289:of the
281:of the
273:of the
265:of the
257:of the
130:of the
108:Austria
52:Austria
997:
987:
979:
939:
931:
890:
880:
872:
831:
821:
813:
774:
766:
702:940450
700:
692:
684:
648:
640:
632:
597:
557:
518:
510:
471:
432:
422:
391:
381:
285:, the
277:, the
269:, the
261:, the
255:-Award
246:Awards
104:Vienna
84:Fields
48:Vienna
911:Blood
698:S2CID
646:S2CID
516:S2CID
1050:2020
1025:2020
995:PMID
977:ISSN
937:PMID
929:ISSN
888:PMID
870:ISSN
829:PMID
811:ISSN
772:PMID
764:ISSN
727:2020
690:PMID
682:ISSN
638:PMID
630:ISSN
595:PMID
555:PMID
508:PMID
469:PMID
430:PMID
420:ISBN
389:PMID
379:ISBN
352:2020
327:2020
222:and
150:and
114:and
31:Born
985:PMC
969:doi
919:doi
915:116
878:PMC
860:doi
819:PMC
803:doi
799:157
754:doi
674:doi
670:124
622:doi
587:doi
577:".
547:doi
537:".
500:doi
496:179
490:".
461:doi
451:".
412:doi
371:doi
182:WHO
1078::
1041:.
1016:.
993:.
983:.
975:.
963:.
959:.
935:.
927:.
913:.
909:.
886:.
876:.
868:.
856:20
854:.
850:.
827:.
817:.
809:.
797:.
793:.
770:.
762:.
750:37
748:.
744:.
718:.
696:.
688:.
680:.
668:.
644:.
636:.
628:.
616:.
593:.
583:25
581:.
553:.
543:23
541:.
514:.
506:.
494:.
467:.
457:15
455:.
428:.
418:.
387:.
377:.
343:.
317:.
297:.
218:,
214:,
166:.
106:,
50:,
39:)
1052:.
1027:.
1001:.
971::
965:8
943:.
921::
894:.
862::
835:.
805::
778:.
756::
729:.
704:.
676::
652:.
624::
618:3
601:.
589::
573:"
561:.
549::
522:.
502::
475:.
463::
436:.
414::
395:.
373::
354:.
329:.
35:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.